GMX Reliance Gen.

RNS Number:7540Q
GeneMedix PLC
05 February 2007



                                                               5th February 2007

                                  GeneMedix Plc

                    Proposed Consolidation of Ordinary Shares

GeneMedix plc ("GeneMedix" or "the Company"), the UK biopharmaceutical company
listed on the London and Singapore Stock Exchanges, announces details of its
proposed consolidation of shares.

The Company will be moving its Official Listing on the London Stock Exchange to
the AIM market on 12th February 2007 and will effect the consolidation of its
existing Ordinary Shares at that stage. Existing Ordinary Shares have a nominal
value of 1p and these will be consolidated on the basis of 10 existing Ordinary
Shares for 1 new consolidated Ordinary Share, which will have a nominal value of
10p. The consolidation will not affect the rights of Shareholders that currently
attach to the Ordinary Shares.

To implement the share consolidation, it may be necessary to issue a small
number of Ordinary Shares for cash so that the number of consolidated Ordinary
Shares in issue post-consolidation is a whole number.

The consolidation of shares will take place on both the London and Singapore
Stock Exchanges.


ENQUIRIES:

GeneMedix plc                                                 Tel: 01638 663320
Julian Attfield, Chief Executive Officer

Bankside Consultants                                          Tel: 020 7367 8888
Susan Scott / Daniela Hale










                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCOKPKNOBKDFBK

Reliance Genemedix (LSE:GMX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Reliance Genemedix (LSE:GMX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025